69815-53-8 Usage
Description
(2-methyl-1-naphthyl)acetonitrile, with the molecular formula C13H11N, is a nitrile derivative of 2-methyl-1-naphthylacetic acid. It is a chemical compound that serves as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Known for its high purity and stability, it is a valuable building block in the production of various drugs, including nonsteroidal anti-inflammatory drugs (NSAIDs) and chemotherapeutic agents.
Uses
Used in Pharmaceutical Industry:
(2-methyl-1-naphthyl)acetonitrile is used as an intermediate for the synthesis of various drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and chemotherapeutic agents, due to its versatile reactivity and ability to form complex molecular structures.
Used in Agrochemical Industry:
(2-methyl-1-naphthyl)acetonitrile is used as a building block in the development of agrochemicals, contributing to the creation of effective compounds for agricultural applications.
Used in Organic Synthesis and Research:
(2-methyl-1-naphthyl)acetonitrile is used as a versatile reagent in organic synthesis and research, enabling the construction of complex molecular structures and aiding in the development of new chemical entities for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 69815-53-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,8,1 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 69815-53:
(7*6)+(6*9)+(5*8)+(4*1)+(3*5)+(2*5)+(1*3)=168
168 % 10 = 8
So 69815-53-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H11N/c1-10-6-7-11-4-2-3-5-13(11)12(10)8-9-14/h2-7H,8H2,1H3
69815-53-8Relevant articles and documents
Arylsulfonamide ethers, and methods of use thereof
-
, (2008/06/13)
Novel arylsulfonamide ether compounds and pharmaceutical compositions thereof are described. The use of the novel arylsulfonamide ether compounds and pharmaceutical compositions thereof as inhibitors of interleukin-1β converting enzyme and other cysteine proteases in the ICE family is also decribed. In addition, methods of treating stroke, inflammatory diseases, septic shock, repurfusion injury, Alzheimer's disease, and shigellosis using a compound of the invention or a pharmaceutical composition thereof are described.
